Ninety One UK Ltd Trims Position in West Pharmaceutical Services, Inc. (NYSE:WST)

Ninety One UK Ltd cut its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 5.2% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 32,526 shares of the medical instruments supplier’s stock after selling 1,800 shares during the period. Ninety One UK Ltd’s holdings in West Pharmaceutical Services were worth $10,714,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also made changes to their positions in WST. Evoke Wealth LLC purchased a new position in West Pharmaceutical Services in the fourth quarter valued at about $7,770,000. Sumitomo Mitsui Trust Holdings Inc. increased its position in West Pharmaceutical Services by 1.5% during the 1st quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 191,469 shares of the medical instruments supplier’s stock valued at $75,766,000 after buying an additional 2,759 shares in the last quarter. Vanguard Group Inc. raised its stake in West Pharmaceutical Services by 1.2% in the fourth quarter. Vanguard Group Inc. now owns 9,002,632 shares of the medical instruments supplier’s stock valued at $3,170,007,000 after buying an additional 104,740 shares during the last quarter. Mizuho Markets Americas LLC grew its stake in shares of West Pharmaceutical Services by 142.3% during the first quarter. Mizuho Markets Americas LLC now owns 29,628 shares of the medical instruments supplier’s stock worth $11,724,000 after acquiring an additional 17,399 shares during the last quarter. Finally, Hsbc Holdings PLC raised its position in shares of West Pharmaceutical Services by 39.8% in the 4th quarter. Hsbc Holdings PLC now owns 138,468 shares of the medical instruments supplier’s stock valued at $48,750,000 after purchasing an additional 39,392 shares during the last quarter. 93.90% of the stock is currently owned by hedge funds and other institutional investors.

West Pharmaceutical Services Stock Performance

WST stock traded down $0.99 during trading on Tuesday, reaching $300.69. The company had a trading volume of 59,230 shares, compared to its average volume of 568,094. The company has a market cap of $21.81 billion, a price-to-earnings ratio of 39.80, a price-to-earnings-growth ratio of 10.68 and a beta of 1.00. West Pharmaceutical Services, Inc. has a twelve month low of $265.00 and a twelve month high of $415.73. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.68 and a current ratio of 2.34. The firm has a 50-day simple moving average of $314.46 and a 200-day simple moving average of $349.20.

West Pharmaceutical Services (NYSE:WST) last posted its quarterly earnings results on Thursday, July 25th. The medical instruments supplier reported $1.52 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.74 by ($0.22). The business had revenue of $702.10 million for the quarter, compared to analysts’ expectations of $729.36 million. West Pharmaceutical Services had a return on equity of 19.17% and a net margin of 18.25%. The business’s quarterly revenue was down 6.9% compared to the same quarter last year. During the same period in the prior year, the business posted $2.11 earnings per share. As a group, sell-side analysts expect that West Pharmaceutical Services, Inc. will post 6.44 earnings per share for the current year.

Insider Activity at West Pharmaceutical Services

In other West Pharmaceutical Services news, SVP Silji Abraham sold 1,800 shares of West Pharmaceutical Services stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of $330.78, for a total transaction of $595,404.00. Following the completion of the transaction, the senior vice president now owns 2,860 shares in the company, valued at approximately $946,030.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.53% of the stock is currently owned by insiders.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.